| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |